$FLR | Fluor Corp. Q2'25 Earnings Highlights 🔹 Revenue: $4.00B (Est. $4.55B) 🔴; -6% YoY 🔹 Adj. EPS: $0.43 (Est. $0.56) 🔴; -49% YoY
$FLR (-17.0% pre) Fluor: Q2 Earnings Snapshot https://t.co/kK9iacDJbf
$FLGT (+16.4% pre) Fulgent Reports Second Quarter 2025 Financial Results https://t.co/vMkBKT7zM5
Confluent reported its fiscal second-quarter 2025 results with revenue of $282.3 million, surpassing estimates of $278.4 million, and adjusted earnings per share (EPS) of $0.09, beating the $0.08 consensus. The company posted an adjusted operating income of $17.8 million and an operating margin of 6.3%. For the full fiscal year 2025, Confluent reaffirmed its adjusted EPS guidance of $0.36 and operating margin guidance of 6%, although it expects third-quarter revenue to fall below consensus. Despite beating on revenue and EPS, Confluent's stock declined sharply, falling nearly 30% after hours, primarily due to cautious cloud business guidance and being perceived as less involved in the AI sector. Albemarle Corp. reported second-quarter 2025 revenue of $1.33 billion, exceeding the $1.22 billion estimate, with adjusted EPS of $0.11, well above the estimated loss of $0.78 per share. The company saw volume growth in its Energy Storage segment by 15% and Specialties by 6%. Albemarle lowered its capital expenditure outlook for 2025 to $650 million–$700 million and maintained its full-year earnings assumptions based on a lithium price of $9 per kilogram. The company expects to generate positive free cash flow in 2025 and has implemented cost-cutting measures in response to declining lithium prices. Fluor Corp. reported second-quarter 2025 revenue of $4.00 billion, missing estimates of $4.55 billion and representing a 6% year-over-year decline. Adjusted EPS came in at $0.43, below the $0.56 consensus and down 49% compared to the prior year. Fluor lowered its full-year 2025 adjusted EPS guidance to a range of $1.95 to $2.15 from $2.25 to $2.75 and reduced its EBITDA outlook to $475 million–$525 million from $575 million–$675 million. Following the earnings release and lowered outlook, Fluor's stock fell 17%. Fulgent also reported its second-quarter 2025 financial results, with its stock rising 16.4% in pre-market trading.
